Blood News and Research

RSS

Media outlets examine how AIDS vaccine trial results will shape future studies

As the AIDS vaccine conference continues in Paris this week, Reuters examines how recent trials are helping researchers better understand ways to develop a vaccine that offers people protection from HIV.

22 Oct 2009

Positive results from Isis Pharmaceuticals' ISIS 113715 Phase 2 study in type 2 diabetes patients

Isis Pharmaceuticals, Inc. today announced positive top-line results from a Phase 2 study evaluating the safety and efficacy of ISIS 113715 in patients with type 2 diabetes. ISIS 113715 is a novel insulin sensitizer that reduces the expression of protein tyrosine phosphatase-1B (PTP-1B). The study showed consistent and statistically significant reductions in multiple short and intermediate measures of glucose control.

22 Oct 2009

Gates Foundation awards Vanderbilt University $100,000 for developing a malaria diagnostic test

Vanderbilt University announced Oct. 21 that it has received a $100,000 Grand Challenges Explorations grant from the Bill & Melinda Gates Foundation. The grant will support an innovative global health research project conducted by Associate Professor of Chemistry David Wright and Professor of Biomedical Engineering Rick Haselton, titled "Coffee Ring Stain Diagnostics for Malaria."

22 Oct 2009

Crux Biomedical receives U.S. patent for its novel vena cava filter

Crux Biomedical Inc. announced today that it was awarded a U.S. patent, (US 7,582,100 B2), for its novel vena cava filter.

22 Oct 2009

AAAS and partners to launch online social-networking sites for scientists

To help scientists and science trainees who hope to translate laboratory research into clinical medicine and to help minority scientists navigate their career paths, AAAS, Science Careers, and Science are launching a pair of online social-networking sites.

22 Oct 2009

New diabetes algorithm released by AACE for the management of type 2 diabetes

A new, first-of-its-kind diabetes algorithm created to help achieve glycemic (blood sugar) control in type 2 patients was published online today in the September/October edition of Endocrine Practice.

22 Oct 2009

NIH awards $8 million to The Medical College of Wisconsin for heart research

The Medical College of Wisconsin has been awarded a five-year, $8 million, multi-investigator Program Project Grant (PPG) from the National Institutes of Health to understand how human pluripotent stem cells, defined as cells which if left to their own designs can develop into any of the more than 200 cell types in the human body, can be channeled to exclusively become heart muscle cells.

22 Oct 2009

Research suggests latent cytomegalovirus infection exacerbates inflammatory bowel disease

Current research suggests that latent cytomegalovirus (CMV) infection may exacerbate inflammatory bowel disease (IBD). The related report by Onyeagocha et al, "Latent cytomegalovirus infection exacerbates experimental colitis," appears in the November 2009 issue of The American Journal of Pathology.

21 Oct 2009

Northwest Biotherapeutics announces long-term data from Phase I and Phase I/II clinical trials of DCVax-Brain

Northwest Biotherapeutics, Inc. today announced further long-term follow-up data, for the period from January through September 2009, from its prior Phase I and Phase I/II clinical trials conducted at UCLA with DCVax®-Brain in patients with Glioblastoma multiforme ("GBM"). GBM is the most rapid and lethal type of brain cancer. During the update period, only one of the twenty patients treated with DCVax®-Brain (in addition to standard of care) died, and that patient had survived for nearly 7 years (80.5 months).

21 Oct 2009

The Century Council provides $100,000 research grant to EMF

As part of a multi-faceted initiative geared to significantly reduce college binge drinking and coinciding with National Collegiate Alcohol Awareness Week, The Century Council, a not-for-profit organization funded by distillers dedicated to fighting drunk driving and underage drinking, has provided a $100,000 research grant to the Emergency Medicine Foundation (EMF) to learn more about the role of emergency services with regard to college binge drinking.

21 Oct 2009

Gamida Cell and Cellerixon collaborate to develop new line of cell therapeutics

Gamida Cell Ltd. and Cellerix, S.A. announced today that the companies are collaborating on a feasibility study to evaluate the added value of combining the proprietary technologies of each.

21 Oct 2009

Maternal smoking may increase the level of distress of newborns, says study

A new research study being published in the October 15th issue of Biological Psychiatry suggests that maternal smoking may increase the level of distress of newborns.

21 Oct 2009

Study reveals a dramatic increase in TTB cases

Babesiosis is a potentially dangerous parasitic disease transmitted by ticks and is common in the Northeast and the upper Midwest. Babesia lives inside of red blood cells, meaning it can also be transmitted through a blood transfusion from an infected but otherwise asymptomatic blood donor.

21 Oct 2009

Aethlon Hemopurifier effective in capturing H1N1 Swine Flu Virus

Aethlon Medical, Inc. announced today that research studies have documented the Aethlon Hemopurifier® is effective in capturing the current pandemic strain of the H1N1 Swine Flu Virus. The Hemopurifier® is the first-in-class medical device able to selectively remove infectious viruses and immunosuppressive proteins from the bloodstream.

21 Oct 2009

New results from ADVANCE provide important insights to reduce diabetes complications

New results from ADVANCE (Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation), the largest clinical trial ever performed in patients with type 2 diabetes worldwide, provide important insights into the therapeutic strategy to adopt for efficient and safe blood glucose control aimed at the reduction of severe diabetes complications.

21 Oct 2009

Carcinoembryonic antigen co-discoverer Dr. Phil Gold to be inducted into The Canadian Medical Hall of Fame

Prof. Heather Munroe-Blum, Principal and Vice-Chancellor of McGill University, and the Hon. Arthur T. Porter, Director General and CEO of the McGill University Health Centre (MUHC), welcome the news that Dr. Phil Gold is to be inducted into The Canadian Medical Hall of Fame. In 1965, Dr. Gold co-discovered the carcinoembryonic antigen (CEA), the first clinically useful human tumour marker that revolutionized the diagnosis and management of cancer.

21 Oct 2009

MIRP surgery carries higher risk of impotence and incontinence than traditional surgery

A new study debating the effectiveness of minimally invasive prostate surgery is not telling the whole story, warns Dr. David B. Samadi, Chief of the Division of Robotics and Minimally Invasive Surgery in the Department of Urology at The Mount Sinai Medical Center in New York.

21 Oct 2009

Study of aldosterone antagonist usage among patients hospitalised with heart failure published

A study published today in JAMA (October 21) by Nancy M. Albert and colleagues, exploring aldosterone antagonist usage among US patients hospitalised with heart failure, found that only one-third of patients meeting current US Clinical Practice Guidelines criteria were actually being treated.

21 Oct 2009

Cheering for your favorite baseball team: Is it hazardous to your health?

A study, led by cardiologist, Dr. Franklin Zimmerman of Columbia University, will use an ambulatory blood pressure monitor (ABPM) to determine whether cheering for your favorite baseball team is hazardous to your health.

21 Oct 2009

APP Pharmaceuticals to launch Chlorothiazide Sodium for Injection

APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market Chlorothiazide Sodium for Injection, USP. APP expects to launch Chlorothiazide Sodium for Injection, USP in the fourth quarter of 2009.

21 Oct 2009

Blood News and Research

Media outlets examine how AIDS vaccine trial results will shape future studies

Positive results from Isis Pharmaceuticals' ISIS 113715 Phase 2 study in type 2 diabetes patients

Gates Foundation awards Vanderbilt University $100,000 for developing a malaria diagnostic test

Crux Biomedical receives U.S. patent for its novel vena cava filter

AAAS and partners to launch online social-networking sites for scientists

New diabetes algorithm released by AACE for the management of type 2 diabetes

NIH awards $8 million to The Medical College of Wisconsin for heart research

Research suggests latent cytomegalovirus infection exacerbates inflammatory bowel disease

Northwest Biotherapeutics announces long-term data from Phase I and Phase I/II clinical trials of DCVax-Brain

The Century Council provides $100,000 research grant to EMF

Gamida Cell and Cellerixon collaborate to develop new line of cell therapeutics

Maternal smoking may increase the level of distress of newborns, says study

Study reveals a dramatic increase in TTB cases

Aethlon Hemopurifier effective in capturing H1N1 Swine Flu Virus

New results from ADVANCE provide important insights to reduce diabetes complications

Carcinoembryonic antigen co-discoverer Dr. Phil Gold to be inducted into The Canadian Medical Hall of Fame

MIRP surgery carries higher risk of impotence and incontinence than traditional surgery

Study of aldosterone antagonist usage among patients hospitalised with heart failure published

Cheering for your favorite baseball team: Is it hazardous to your health?

APP Pharmaceuticals to launch Chlorothiazide Sodium for Injection

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News